The Breast Oncology Lab at the Hadassah Cancer Research Institute, led by Dr. Paluch-Shimon, is devoted to advancing clinical studies for the detection and prevention of breast cancer in young women. Current projects are focused on BRCA-associated breast cancer and triple negative breast cancer and neo-adjuvant therapies. The goal of this research is to provide a more personalized and precise treatment for breast cancer patients, and Shani and her team believe this can be accomplished by acknowledging that breast cancer is not one illness, and that treatment must be specifically tailored to the biology of an individual patient.
In addition to her responsibilities at HCRI, Shani is the subject editor for breast cancer treatment guidelines for the European Society of Medical Oncology, key-faculty in several international oncology societies & multi-stake holder organizations and member of the Israeli National Cancer Council. She completed the Talpiot physician leadership program at Sheba Medical Center and holds a masters degree in epidemiology from the London School of Hygiene & Tropical Medicine.